S
Suzette Oelofse
Researcher at University of Cape Town
Publications - 18
Citations - 392
Suzette Oelofse is an academic researcher from University of Cape Town. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 9 publications receiving 246 citations.
Papers
More filters
Journal ArticleDOI
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Sergey Borisov,Keertan Dheda,Martin Enwerem,Rodolfo Romero Leyet,Lia D'Ambrosio,Rosella Centis,Giovanni Sotgiu,Simon Tiberi,Simon Tiberi,Jan-Willem C. Alffenaar,Andrey Maryandyshev,Evgeny Belilovski,Shashank Ganatra,Alena Skrahina,Onno W. Akkerman,Alena Aleksa,Rohit Amale,Janina Artsukevich,Judith Bruchfeld,Jose A. Caminero,Isabel Carpena Martinez,Luigi Codecasa,Margareth Pretti Dalcolmo,Justin T Denholm,Paul Douglas,Raquel Duarte,Aliasgar Esmail,Mohammed Fadul,Alexey Filippov,Lina Davies Forsman,Mina Gaga,Julia Amaranta Garcia-Fuertes,José-María García-García,Gina Gualano,Jerker Jonsson,Heinke Kunst,Jillian S.Y. Lau,Barbara Lazaro Mastrapa,Jorge Lazaro Teran Troya,Selene Manga,Katerina Manika,Pablo González Montaner,Jai B Mullerpattan,Suzette Oelofse,Martina Ortelli,Domingo Palmero,Fabrizio Palmieri,Antonella Papalia,Apostolos Papavasileiou,Marie-Christine Payen,Emanuele Pontali,Carlos Robalo Cordeiro,Laura Saderi,Tsetan Dorji Sadutshang,Tatsiana Sanukevich,Varvara Solodovnikova,Antonio Spanevello,Sonam Topgyal,Federica Toscanini,Adrian R Tramontana,Zarir F Udwadia,Pietro Viggiani,Veronica White,Alimuddin Zumla,Giovanni Battista Migliori +64 more
TL;DR: Bedaquiline-containing regimens achieved high conversion and success rates under different nonexperimental conditions, and is safe and effective in treating MDR- and XDR-TB patients.
Journal ArticleDOI
Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
Olatunde Olayanju,Jason Limberis,Aliasgar Esmail,Suzette Oelofse,Phindile Gina,Elize Pietersen,Mohammed Fadul,Rob Warren,Keertan Dheda +8 more
TL;DR: XDR-TB patients receiving a backbone of bedaquiline and linezolid had substantially better favourable outcomes compared to those not using these drugs, which inform the selection of XDR- TB treatment regimens and roll-out of newer drugs in TB-endemic countries.
Journal ArticleDOI
An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells
Michele Tomasicchio,Lynn Semple,Aliasgar Esmail,Richard Meldau,Philippa Randall,Anil Pooran,Malika Davids,Lydia Cairncross,David Anderson,Jennifer Downs,Francois Malherbe,Nicolas Novitzky,Eugenio Panieri,Suzette Oelofse,Rolanda Londt,Thurandrie Naiker,Keertan Dheda +16 more
TL;DR: A DC vaccine that is cytotoxic to autologous breast cancer cells in vitro is developed and the tools and technology generated here will be applied to a phase I/IIa clinical trial.
Journal ArticleDOI
Alone But Supported : A Qualitative Study of an HIV Self-testing App in an Observational Cohort Study in South Africa
Ricky Janssen,Nora Engel,Aliasgar Esmail,Suzette Oelofse,Anja Krumeich,Keertan Dheda,Keertan Dheda,Nitika Pant Pai +7 more
TL;DR: The adaptable access and support of this strategy could aid in expanding test access in South Africa and the flexibility and support provided by the strategy gave participants more control in choosing whom they included during testing.
Journal ArticleDOI
Impact of a personalised, digital, HIV self-testing app-based program on linkages and new infections in the township populations of South Africa.
Nitika Pai,Aliasgar Esmail,Paramita Saha Chaudhuri,Suzette Oelofse,Marietjie Pretorius,Gayatri Marathe,Jana Daher,Megan Smallwood,Nicolaos Karatzas,Mohammed Fadul,Anna de Waal,Nora Engel,Alice Zwerling,Keertan Dheda,Keertan Dheda +14 more
TL;DR: In this paper, the authors evaluated the impact of an app-based, personalised, oral HIV self-testing (HIVST) program offered by healthcare workers in Western Cape, South Africa.